LoginRegister
    Siddhivinayak Trust to provide Rs 10 crore for pneumococcal vaccination driveSiddhivinayak Trust to provide Rs 10 crore for pneumococcal vaccination drive
    OBI Pharma gets USFDA clearance for OBI-999 to treat pancreatic cancerOBI Pharma gets USFDA clearance for OBI-999 to treat pancreatic cancer
    Luye Pharma seeks USFDA nod for antidepressant drug LY03005Luye Pharma seeks USFDA nod for antidepressant drug LY03005
    JnJ to pay Rs 230 crore fine for not passing GST rate cut benefits to customersJnJ to pay Rs 230 crore fine for not passing GST rate cut benefits to customers
    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020Indira IVF to invest Rs 80 crore to expand presence in south India by 2020
    IIT-Roorkee develops bioresorbable, economical ortho implants to heal bone fracturesIIT-Roorkee develops bioresorbable, economical ortho implants to heal bone fractures
    Towa Pharma to acquire ESTEVE generic division Pensa Investments for 320 million eurosTowa Pharma to acquire ESTEVE generic division Pensa Investments for 320 million euros
    Immunomedics BLA resubmission for sacituzumab govitecan to treat breast cancer accepted by USFDAImmunomedics BLA resubmission for sacituzumab govitecan to treat breast cancer accepted by USFDA
    Spring Bank Pharma halts dosing of Inarigivir patients in phase-2 trial to treat chronic HBVSpring Bank Pharma halts dosing of Inarigivir patients in phase-2 trial to treat chronic HBV
    Granules India Independent Director C Parthasarathy resignsGranules India Independent Director C Parthasarathy resigns
    Zydus Cadila to divest two major units- Vivo, Gynova for Rs 1200 crore: ReportZydus Cadila to divest two major units- Vivo, Gynova for Rs 1200 crore: Report
    Lupin Ankleshwar facility wins India Manufacturing Excellence Awards 2019Lupin Ankleshwar facility wins India Manufacturing Excellence Awards 2019
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X